Verification evidence is still being completed.
Scope Fluidics
Warsaw, Poland
- Verified lead
- Piotr Garstecki
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President of the Management Board
- 2026 technical specialization
- Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics
- Review cycle
- May 2026
- Full address
- Ogrodowa 58, 9th floor, 00-876 Warsaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Scope Fluidics page confirming the Warsaw headquarters address.
- Editorial note
- Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.
Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics
Official leadership disclosure, Official Warsaw address disclosure, Diagnostics platform claim
Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.
Scope Fluidics
Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics · Diagnostics platform
Scope Fluidics runs microfluidic diagnostics development, point-of-care platform development, and amr diagnostics programs in Warsaw, Poland.
- Lead
- Piotr Garstecki (verified ↗)
- Address
- Ogrodowa 58, 9th floor, 00-876 Warsaw, Poland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- Microfluidic Diagnostics Development · Point-of-Care Platform Development · AMR Diagnostics Programs
- Founded
- 2010
- Headcount
- 51-200
- Company page (open ↗)
Piotr Garstecki
President of the Management Board
Official Scope Fluidics page listing the Warsaw headquarters address.
Open sourceDiagnostics platform
Warsaw, Poland. Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics. Review completed on 22 Mar 2026.
Polish diagnostics and medtech oversight
Official leadership disclosure, Official Warsaw address disclosure, Diagnostics platform claim
Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics
Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.
Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Scope Fluidics located?
- Scope Fluidics operates from Ogrodowa 58, 9th floor, 00-876 Warsaw, Poland, Warsaw, Poland.
- Who runs Scope Fluidics?
- Scope Fluidics is led by Piotr Garstecki, President of the Management Board. Verified 22 Mar 2026.
- What does Scope Fluidics do?
- Scope Fluidics runs microfluidic diagnostics development, point-of-care platform development, and amr diagnostics programs in Warsaw, Poland. Core capabilities: Microfluidic Diagnostics Development, Point-of-Care Platform Development, AMR Diagnostics Programs.
Related technical briefs
Briefs that name Warsaw as a covered market or city.
